Hence then, the article about biocity announces initiation of a phase 2 trial for sc0062 a promising eta receptor antagonist for chronic kidney disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease )
Last updated :
Also on site :
- The Wailers and The Pogues Confirm Australian Tours Despite Bluesfest Collapse
- Joseph Duggar's Wife Kendra Duggar's Mugshot Revealed After Arrest
- Numbrix 9 - March 21